Skip to main content
6769 search results for:

Ceftazidime 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | News

    Ceftazidime/piperacillin/tazobactam

    Lack of efficacy
  2. 15-04-2024 | Ceftazidime | Online First

    Performance of two immunochromatographic tests in detecting KPC variants conferring resistance to ceftazidime-avibactam

  3. 01-03-2024 | Ceftazidime | News

    Ceftazidime/Piperacillin/tazobactam

    Lack of efficacy
  4. 01-03-2024 | Ceftazidime | News

    Ceftazidime

    Neurotoxicity in the form of encephalopathy
  5. 01-03-2024 | Ceftazidime | News

    Ceftazidime/Doxycycline/Vancomycin

    Lack of efficacy
  6. 03-05-2024 | Aztreonam | Online First

    In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex

    In recent years, carbapenem-resistant Enterobacteriaceae (CRE) has emerged as the primary cause of clinical anti-infective treatment failure, posing a significant threat to clinical treatment [ 1 ]. Among Enterobacteriaceae , Enterobacter cloacae …Enterobacter kobei

  7. 01-02-2024 | Ceftazidime | News

    Ceftazidime

    Subacute neurotoxicity
  8. 02-02-2024 | Ceftazidime | Online First

    Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review

    Ceftazidime is a third-generation cephalosporin used in the treatment of P. aeruginosa infections. Besides, it is a preferred treatment option in patients with hematologic malignancies suffering from neutropenic fever. It is currently also used as …

  9. Open Access 22-02-2024 | Ceftazidime | Online First

    Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5

    Since Salmonella enterica serovar 1,4,[5], 12: i:-( S. 1,4,[5], 12: i:-) was reported in Spain in 1997 [ 1 ], the detection rate has increased and in recent years has surpassed Salmonella enterica serovar typhimurium (STM) as the most common …

  10. Open Access 11-09-2023 | Ceftazidime | OriginalPaper

    Ceftazidime-avibactam alone or in combination with Aztreonam versus Polymyxins in the management of carbapenem-Resistant Klebsiella pneumoniae nosocomial Infections (CAPRI study): a retrospective cohort study from South India

    Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a common cause of hospital-acquired infections in endemic regions. Traditionally, polymyxins with or without other antibiotics are used for the treatment of CRKP infections, but their …

  11. 13-01-2024 | Meropenem | Online First

    Inoculum effect of CTX-M-15, OXA-48, and KPC-2 producing Klebsiella pneumoniae on meropenem and ceftazidime-avibactam efficacy

    The inoculum effect, characterized by diminished antibacterial activity at high bacterial inocula, is studied in the context of beta-lactam and beta-lactamase inhibitor combinations against beta-lactamase-producing Enterobacterales. The inhibition …

  12. Open Access 21-11-2023 | Ceftazidime | OriginalPaper

    Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022)

    Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) emerged globally as one of the most clinically relevant pathogen in view of its wide dissemination in healthcare facilities, the limited number of effective treatment …

  13. Open Access 25-10-2023 | Carbapenem Antibiotic | ReviewPaper

    Ceftazidime–avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis

    In recent decades, carbapenem-resistant Enterobacteriaceae (CRE) have been identified by the World Health Organization as a formidable medical threat to public health [ 1 , 2 ]. Infections caused by CRE resulted in extremely high morbidity and …

  14. 01-11-2023 | Vancomycin | News

    Ceftazidime/vancomycin

    Lack of efficacy: case report
  15. 07-11-2023 | Meropenem | BriefCommunication

    Evaluation of the ceftazidime/avibactam and meropenem susceptibility by MALDI-TOF MS directly from positive blood cultures

    The purpose of this study was to evaluate the MBT-ASTRA to determine susceptibility to ceftazidime/avibactam (CZA) and meropenem (MEM) of Enterobacterales directly from positive blood cultures (BC). Bacterial suspension was incubated with …

  16. 01-11-2023 | Ceftazidime | News

    Ceftazidime

    Lack of efficacy: case report
  17. 01-02-2023 | Magaldrate | News

    Ceftazidime/ferric carboxymaltose/magaldrate

    Hypophosphataemia: case report
  18. Open Access 01-12-2023 | Carbapenem Antibiotic | OriginalPaper

    Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection

    The rapid global emergence and spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB), particularly carbapenem-resistant Gram-negative bacilli (CR-GNB), is recognized as a major public health concern …

  19. 01-09-2023 | Ceftazidime | News

    Ceftazidime/vancomycin

    Lack of efficacy: case report
  20. Open Access 01-12-2023 | Meningitis | OriginalPaper

    Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study

    Despite advances in medicine, neurosurgery, antimicrobial therapy, and critical care, meningitis, specifically nosocomial or healthcare-associated meningitis (HCAM), still poses a significant risk of mortality and morbidity [ 1 – 3 ]. Prompt and …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.